Approval and launch of new products is expected to propel growth of the global COVID-19 nasal swab test market over the forecast period. For example, the World Health Organization, in May 2021, approved Abbott Rapid Diagnostics Jena GmbH to include its nasal swab specimen based Panbio rapid antigen COVID-19 test in emergency use listing.
Get PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/4629
Funding for R&D in diagnostics solutions for COVID-19 is expected to offer lucrative growth opportunities for players in the global COVID-19 nasal swab test market. For example, Puritan Medical Products Company, LLC, in November 2020, received a funding of around US$ 11.6 million to boost its testing efficiency.
The global COVID-19 nasal swab test market is witnessing launch of affordable products. For example, in July 2020, the Government of India launched an affordable COVID-19 test. The swab-based RT-PCR test, developed by Indian Institute of Technology, Delhi, costs INR 399 (US$ 5.34).
Major players operating in the global COVID-19 nasal swab test market are focused on adopting partnership strategies to enhance their market share. For example, in April 2020, Novacyt, a biotechnology company, collaborated with the University of Cambridge, U.K., GlaxoSmithKline plc. and AstraZeneca plc. to establish a new laboratory for COVID-19 testing.
Major players operating in the global COVID-19 nasal swab test market include, 3M Corporation, Abbott Laboratories, Becton Dickinson & Company, BioMerieux SA, Cepheid, GenMark Diagnostics, Inc., LumiraDx Ltd., Fluidigm Corporation, Lucira Health, Mesa Biotech, Inc., OraSure Technologies, Inc., PrivaPath Diagnostics Limited, QIAGEN N.V., Quidel Corporation, Roche Holding AG, Siemens Healthineers AG, and Sherlock Biosciences.
Request Here For PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/4629
Major players operating in the global COVID-19 nasal swab test market are focused on approval and launch of new products to expand their product portfolio. For example, the European Union granted CE mark to Roche Diagnostics’ rapid antigen COVID-19 nasal swab test, in February 2021.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 COVID-19 Nasal Swab Test Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: COVID-19 Nasal Swab Test Industry Impact
Chapter 2 Global COVID-19 Nasal Swab Test Competition by Types, Applications, and Top Regions and Countries
2.1 Global COVID-19 Nasal Swab Test (Volume and Value) by Type
2.3 Global COVID-19 Nasal Swab Test (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global COVID-19 Nasal Swab Test Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America COVID-19 Nasal Swab Test Market Analysis
Chapter 6 East Asia COVID-19 Nasal Swab Test Market Analysis
Chapter 7 Europe COVID-19 Nasal Swab Test Market Analysis
Chapter 8 South Asia COVID-19 Nasal Swab Test Market Analysis
Chapter 9 Southeast Asia COVID-19 Nasal Swab Test Market Analysis
Chapter 10 Middle East COVID-19 Nasal Swab Test Market Analysis
Chapter 11 Africa COVID-19 Nasal Swab Test Market Analysis
Chapter 12 Oceania COVID-19 Nasal Swab Test Market Analysis
Chapter 13 South America COVID-19 Nasal Swab Test Market Analysis
Chapter 14 Company Profiles and Key Figures in COVID-19 Nasal Swab Test Business
Chapter 15 Global COVID-19 Nasal Swab Test Market Forecast (2021-2027)
Chapter 16 Conclusions
Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/4629
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027